#stayhome Maintain the distance, wash your hands, and follow instructions from the health authorities.

POST Online Media Lite Edition


Concordia announces leadership transition at international segment

Staff Writer |
Oakville, ON, Canada - December 28, 2016, Oakville, ON, Canada - Concordia International Corp., a specialty pharmaceutical company, announced that John Beighton will retire from his current role as president of the company's international segment, effective January 1, 2017.

Mr. Beighton will remain with Concordia as a board member of the Company's International segment, where he will continue to be available to provide strategic advice to the International business.

Graeme Duncan, currently Managing Director for the segment, will replace Mr. Beighton as President.

Mr. Duncan joined Amdipharm Mercury Limited (now Concordia's International segment) in 2015 as Global Marketing Director and Vice President, Commercial UK and Ireland.

Mr. Duncan was promoted to Managing Director in 2016 and was responsible for the general management of the segment.

He has worked for 20 years in the life sciences sector within the areas of strategy, sales and marketing, and management.


Medical Facilities hires John Schario as chief operating officer
Minkap Resources appoints Errin Kimball to board
Jaguar Mining appoints Jeff Kennedy as independent non-executive director
Bunker Hill Mining appoints Hugh Aird to board
Scotiabank appoints Tom McGuire as executive vice-president

What to read next

Transition appoints Carl Damiani as president
Concordia appoints CEO, chairman
Ablon Group appoints two diretors